Status:
COMPLETED
Using SMS Reminders, Phone Calls and Money Incentives to Enhance Linkage to Care of Presumptive TB Patients in Uganda
Lead Sponsor:
Makerere University
Conditions:
Tuberculosis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The major challenge in meeting the WHO's End TB Strategy- reducing tuberculosis (TB) deaths by 90% and incidence by 80% is the cascading patient loss-to-follow-up (LTFU) along the continuum of TB care...
Detailed Description
The major challenge in meeting the WHO's End TB Strategy- reducing TB deaths by 90% and incidence by 80% is the cascading patient loss-to-follow-up (LTFU) along the continuum of TB care. Patients can ...
Eligibility Criteria
Inclusion
- Presumptive TB patient (cough, fever, night sweats, weight loss)
- Requested to have GeneXpert testing
- Aged between 18 and 65 years
- Current resident in the study districts
- Willing to sign informed consent
- Owning a mobile phone
- Able to read
Exclusion
- Participant plans to move out of the study area in the next 3 months
- Participation in another related study such as SMS, phone call or mobile money incentive and others
Key Trial Info
Start Date :
August 14 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2024
Estimated Enrollment :
2355 Patients enrolled
Trial Details
Trial ID
NCT05964842
Start Date
August 14 2023
End Date
May 31 2024
Last Update
October 23 2024
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Luwero General Hospital
Luwero, Kasana, Uganda
2
Kiruddu National Referral Hospital
Kampala, Makindye, Uganda
3
Mukono General Hospital
Mukono, Uganda
4
Entebbe Regional Referral Hospital
Wakiso, Uganda